                         SEQUENCE LISTING

<110>  Fraunhofer-Gesellschaft zur Frderung der angewandten 
       Forschung e.V.
 
<120>  Use of CD-64-blocking agents as enhancer of a with anti-TNF-alpha
        antibody therapy

<130>  150496WO

<150>  EP14161731
<151>  2014-03-26

<160>  14    

<170>  PatentIn version 3.3

<210>  1
<211>  747
<212>  DNA
<213>  homo sapiens

<400>  1
atggcccagg tgcagctggt ggagagcggt ggaggtgttg tgcaacctgg ccggtccctg     60

cgcctgtcct gctcctcgtc tggcttcatt ttcagtgaca attacatgta ttgggtgaga    120

caggcacctg gaaaaggtct tgagtgggtt gcaaccatta gtgatggtgg tagttacacc    180

tactatccag acagtgtgaa gggaagattt acaatatcga gagacaacag caagaacaca    240

ttgttcctgc aaatggacag cctgagaccc gaagacaccg gggtctattt ttgtgcaaga    300

ggctactata ggtacgaggg ggctatggac tactggggcc aagggacccc ggtcaccgtg    360

agctcaggag gtggcggctc cggaggtgga ggcagcggag ggggcggatc cgacatccag    420

ctgacccaga gcccaagcag cctgagcgcc agcgtgggtg acagagtgac catcacctgt    480

aagtccagtc aaagtgtttt atacagttca aatcagaaga actacttggc ctggtaccag    540

cagaagccag gtaaggctcc aaagctgctg atctactggg catccactag ggaatctggt    600

gtgccaagca gattcagcgg tagcggtagc ggtaccgact tcaccttcac catcagcagc    660

ctccagccag aggacatcgc cacctactac tgccatcaat acctctcctc gtggacgttc    720

ggccaaggga ccaagctgga gatcaaa                                        747


<210>  2
<211>  278
<212>  PRT
<213>  artificial

<220>
<223>  recombinant antibody fragment

<400>  2

His His His His His His His His His His Ser Ser Gly His Ile Asp 
1               5                   10                  15      


Asp Asp Asp Lys His Met Lys Leu Met Ala Gln Pro Ala Met Ala Gln 
            20                  25                  30          


Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg Ser 
        35                  40                  45              


Leu Arg Leu Ser Cys Ser Ser Ser Gly Phe Ile Phe Ser Asp Asn Tyr 
    50                  55                  60                  


Met Tyr Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val Ala 
65                  70                  75                  80  


Thr Ile Ser Asp Gly Gly Ser Tyr Thr Tyr Tyr Pro Asp Ser Val Lys 
                85                  90                  95      


Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Phe Leu 
            100                 105                 110         


Gln Met Asp Ser Leu Arg Pro Glu Asp Thr Gly Val Tyr Phe Cys Ala 
        115                 120                 125             


Arg Gly Tyr Tyr Arg Tyr Glu Gly Ala Met Asp Tyr Trp Gly Gln Gly 
    130                 135                 140                 


Thr Pro Val Thr Val Ser Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly 
145                 150                 155                 160 


Ser Gly Gly Gly Gly Ser Asp Ile Gln Leu Thr Gln Ser Pro Ser Ser 
                165                 170                 175     


Leu Ser Ala Ser Val Gly Asp Arg Val Thr Ile Thr Cys Lys Ser Ser 
            180                 185                 190         


Gln Ser Val Leu Tyr Ser Ser Asn Gln Lys Asn Tyr Leu Ala Trp Tyr 
        195                 200                 205             


Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile Tyr Trp Ala Ser 
    210                 215                 220                 


Thr Arg Glu Ser Gly Val Pro Ser Arg Phe Ser Gly Ser Gly Ser Gly 
225                 230                 235                 240 


Thr Asp Phe Thr Phe Thr Ile Ser Ser Leu Gln Pro Glu Asp Ile Ala 
                245                 250                 255     


Thr Tyr Tyr Cys His Gln Tyr Leu Ser Ser Trp Thr Phe Gly Gln Gly 
            260                 265                 270         


Thr Lys Leu Glu Ile Lys 
        275             


<210>  3
<211>  21
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  3
acagatgaag tgctccttcc a                                               21


<210>  4
<211>  21
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  4
gtcggagatt cgtagctgga t                                               21


<210>  5
<211>  21
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  5
ggtacatcct cgacggcatc t                                               21


<210>  6
<211>  21
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  6
gtgcctcttt gctgctttca c                                               21


<210>  7
<211>  23
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  7
actgagagtg attgagagtg gac                                             23


<210>  8
<211>  21
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  8
aaccctctgc acccagtttt c                                               21


<210>  9
<211>  23
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  9
cactgctgct gagatgaatg aaa                                             23


<210>  10
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  10
gtctgtaggc aggtcggctc                                                 20


<210>  11
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  artificial

<400>  11
ggagaagggt gaccgactca                                                 20


<210>  12
<211>  17
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  12
ctgcccagac tcggcaa                                                    17


<210>  13
<211>  20
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  13
tgcaccacca actgcttagc                                                 20


<210>  14
<211>  21
<212>  DNA
<213>  artificial

<220>
<223>  primer

<400>  14
ggcatggact gtggtcatga g                                               21


